Citations

Clear

6274 citation(s) found for "To, Andrew".

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022
Greenberg, Peter L. , Stone, Richard M. , Al‐Kali, Aref , Bennett, John M. , Borate, Uma , Brunner, Andrew M. , Chai‐Ho, Wanxing , Curtin, Peter , Castro, Carlos M. de , Deeg, H. Joachim , Dinner, Shira, Foucar, Charles , Gaensler, Karin, Garcia‐Manero, Guillermo , Keel, Sioḃán , Madanat, Yazan F. , Maness, Lori J., Mangan, James K. , McMahon, Christine M. , Patel, Bhumika J. , Sallman, David A. , Shallis, Rory M. , Shami, Paul J. , Varshavsky‐Yanovsky, Asya, Westervelt, Peter, Hollinger, Elizabeth, Shead, Dorothy A. , Hochstetler, Cindy, Madanat, Yazan , Dezern, Amy Elizabeth , Griffiths, Elizabeth A. , Head, David, Jonas, Brian A. , McCurdy, Shannon , Reddy, Vishnu , Thota, Swapna , Hollinger, Elizabeth

Mayo Clinic

Journal of the National Comprehensive Cancer Network | February 7, 2022 | Volume: 20 | Issue: 2 | Pages: 106-117

10.6004/jnccn.2022.0009 | PMID 35130502 Get It

The NCCN Guidelines for Myelodysplastic Syndromes (MDS) provide recommendations for the evaluation, diagnosis, and management of patients with MDS based on a review of clinical evidence that has led to important advances in treatment or has yielded new information on biologic factors that may have prognostic significance in MDS. The multidisciplinary panel of MDS experts meets on an annual basis to update the recommendations. These NCCN Guidelines Insights focus on some of the updates for the 2022 version of the NCCN Guidelines, which include treatment recommendations both for lower-risk and higher-risk MDS, emerging therapies, supportive care recommendations, and genetic familial high-risk assessment for hereditary myeloid malignancy predisposition syndromes.
Improved Survival after Acute Kidney Injury
Kashani, Kianoush , Rule, Andrew D. , Rule, Andrew D , Kashani, Kianoush B

Mayo Clinic

Clinical Journal of the American Society of Nephrology | February 7, 2022 | Volume: 17 | Issue: 2 | Pages: 179-181

10.2215/cjn.16351221 | PMID 35131925 Get It

Appropriate Telemedicine Utilization in Spine Surgery
Iyer, Sravisht, Bovonratwet, Patawut, Samartzis, Dino, Schoenfeld, Andrew J., An, Howard S., Awwad, Waleed, Blumenthal, Scott L., Cheung, Jason P.Y., Derman, Peter B., El-Sharkawi, Mohammad, Freedman, Brett A., Hartl, Roger, Kang, James D., Kim, Han Jo, Louie, Philip K., Ludwig, Steven C., Neva, Marko H., Pham, Martin H., Phillips, Frank M., Qureshi, Sheeraz A., Radcliff, Kris E., Riew, K. Daniel, Sandhu, Harvinder S., Sciubba, Daniel M., Sethi, Rajiv K., Valacco, Marcelo, Zaidi, Hasan A., Zygourakis, Corinna C., Makhni, Melvin C., Iyer, Sravisht, Bovonratwet, Patawut, Samartzis, Dino , Schoenfeld, Andrew J., An, Howard S., Awwad, Waleed Mohammad , Blumenthal, Scott L., Cheung, Jason P.Y., Derman, Peter B., El-Sharkawi, Mohammad Mostafa , Freedman, Brett A., Hartl, Roger, Kang, James D., Kim, Han Jo, Louie, Philip K., Ludwig, Steven C., Neva, Marko H., Pham, Martin H., Phillips, Frank M., Qureshi, Sheeraz A., Radcliff, Kris E., Riew, K. Daniel, Sandhu, Harvinder S., Sciubba, Daniel M., Sethi, Rajiv K., Valacco, Marcelo, Zaidi, Hasan A., Zygourakis, Corinna C., Makhni, Melvin C.

Mayo Clinic

Spine | February 7, 2022 | Volume: 47 | Issue: 8 | Pages: 583-590

10.1097/brs.0000000000004339 | PMID 35125460 Get It

Study Design. Delphi expert panel consensus. Objective. To obtain expert consensus on best practices for appropriate telemedicine utilization in spine surgery. Summary of Background Data. Several studies have shown high patient satisfaction associated with telemedicine during the COVID-19 peak pandemic period as well as after easing of restrictions. As this technology will most likely continue to be employed, there is a need to define appropriate utilization. Methods. An expert panel consisting of 27 spine surgeons from various countries was assembled in February 2021. A two-round consensus-based Delphi method was used to generate consensus statements on various aspects of telemedicine (separated as video visits or audio visits) including themes, such as patient location and impact of patient diagnosis, on assessment of new patients. Topics with ≥75% agreement were categorized as having achieved a consensus. Results. The expert panel reviewed a total of 59 statements. Of these, 32 achieved consensus. The panel had consensus that video visits could be utilized regardless of patient location and that video visits are appropriate for evaluating as well as indicating for surgery multiple common spine pathologies, such as lumbar stenosis, lumbar radiculopathy, and cervical radiculopathy. Finally, the panel had consensus that video visits could be appropriate for a variety of visit types including early, midterm, longer term postoperative follow-up, follow-up for imaging review, and follow-up after an intervention (i.e., physical therapy, injection). Conclusion. Although telemedicine was initially introduced out of necessity, this technology most likely will remain due to evidence of high patient satisfaction and significant cost savings. This study was able to provide a framework for appropriate telemedicine utilization in spine surgery from a panel of experts. However, several questions remain for future research, such as whether or not an in-person consultation is necessary prior to surgery and which physical exam maneuvers are appropriate for telemedicine. Level of Evidence: 4
The Suprasellar Meningioma Patient-Reported Outcome Survey: a disease-specific patient-reported outcome measure for resection of suprasellar meningioma
Khalafallah, Adham M. , Rakovec, Maureen , Burapachaisri, Katemanee , Fung, Shirley , Kozachik, Sharon , Valappil, Benita, Abou‐Al‐Shaar, Hussam , Zenonos, Georgios A. , Gardner, Paul A. , Başkaya, Mustafa K. , Dornbos, David , Roxbury, Christopher R. , Overdevest, Jonathan B. , Lee, Victoria S. , Levy, Joshua M. , Thamboo, Andrew , Schlosser, Rodney J. , London, Nyall R. , Wu, Albert W., Mukherjee, Debraj , Levy, Joshua M , Schlosser, Rodney J , Mukherjee, Debraj , Wang, Eric W , Snyderman, Carl H , Choby, Garret , Kuan, Edward C , Gudis, David A. , Huang, Judy , Bettegowda, Chetan , Rowan, Nicholas R.

Mayo Clinic

Journal of Neurosurgery | February 2, 2022 | Volume: 136 | Issue: 6 | Pages: 1551-1559

10.3171/2021.6.jns21517 | PMID 34874673 Get It

OBJECTIVE Suprasellar meningioma resection via either the transcranial approach (TCA) or the endoscopic endonasal approach (EEA) is an area of controversy and active evaluation. Skull base surgeons increasingly consider patient-reported outcomes (PROs) when choosing an approach. No PRO measure currently exists to assess quality of life for suprasellar meningiomas. METHODS Adult patients undergoing suprasellar meningioma resection between 2013 and 2019 via EEA (n = 14) or TCA (n = 14) underwent semistructured interviews. Transcripts were coded using a grounded theory approach to identify themes as the basis for a PRO measure that includes all uniquely reported symptoms. To assess content validity, 32 patients and 15 surgeons used a Likert scale to rate the relevance of items on the resulting questionnaire and the general Patient-Reported Outcomes Measurement Information System–29 (PROMIS29). The mean scores were calculated for all items and compared for TCA versus EEA patient cohorts by using unpaired t-tests. Items on either questionnaire with mean scores ≥ 2.0 from patients were considered meaningful and were aggregated to form the novel Suprasellar Meningioma Patient-Reported Outcome Survey (SMPRO) instrument. RESULTS Qualitative analyses resulted in 55 candidate items. Relative to patients who underwent the EEA, those who underwent the TCA reported significantly worse future outlook before surgery (p = 0.01), tiredness from medications 2 weeks after surgery (p = 0.001), and word-finding and memory difficulties 3 months after surgery (p = 0.05 and < 0.001, respectively). The items that patients who received a TCA were most concerned about included medication-induced lethargy after surgery (2.9 ± 1.3), blurry vision before surgery (2.7 ± 1.5), and difficulty reading due to blurry vision before surgery (2.7 ± 2.7). Items that patients who received an EEA were most concerned about included blurry vision before surgery (3.5 ± 1.3), difficulty reading due to blurry vision before surgery (2.4 ± 1.3), and problems with smell postsurgery (2.9 ± 1.3). Although surgeons overall overestimated how concerned patients were about questionnaire items (p < 0.0005), the greatest discrepancies between patient and surgeon relevance scores were for blurry vision pre- and postoperatively (p < 0.001 and < 0.001, respectively) and problems with taste postoperatively (p < 0.001). Seventeen meningioma-specific items were considered meaningful, supplementing 8 significant PROMIS29 items to create the novel 25-item SMPRO. CONCLUSIONS The authors developed a disease- and approach-specific measure for suprasellar meningiomas to compare quality of life by operative approach. If demonstrated to be reliable and valid in future studies, this instrument may assist patients and providers in choosing a personalized surgical approach.
Impact of conditioning regimen intensity on the outcomes of peripheral T‐cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T‐cell lymphoma patients undergoing allogeneic transplant
Ahn, Kwang Woo , Ahmed, Sairah , Cashen, Amanda F. , Modi, Dipenkumar , Khimani, Farhad , Zain, Jasmine , Brammer, Jonathan E. , Rezvani, Andrew R. , Fenske, Timothy S. , Sauter, Craig S. , Kharfan‐Dabaja, Mohamed A. , Herrera, Alex F. , Savani, Malvi , Ahmed, Sairah , Modi, Dipenkumar , Hamadani, Mehdi , Chen, Yue , Shadman, Mazyar , Cutler, Corey S. , Hamadani, Mehdi

Mayo Clinic

British Journal of Haematology | February 2, 2022 | Volume: 197 | Issue: 2 | Pages: 212-222

10.1111/bjh.18052 | PMID 35106754 Get It

SummaryThere have been no large studies comparing reduced‐intensity/non‐myeloablative conditioning (RIC/NMA) to myeloablative conditioning (MAC) regimens in T‐cell non‐Hodgkin lymphoma (T‐NHL) patients undergoing allogeneic transplant (allo‐HCT). A total of 803 adults with peripheral T‐cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T‐cell lymphoma (age 18–65 years), undergoing allo‐HCT between 2008–2019 and reported to the Center for International Blood and Marrow Transplant Research with either MAC (n = 258) or RIC/NMA regimens (n = 545) were evaluated. There were no significant differences between the two cohorts in terms of patient sex, race and performance scores. Significantly more patients in the RIC/NMA cohort had peripheral blood grafts, haematopoietic cell transplantation‐specific comorbidity index (HCT‐CI) of ≥3 and chemosensitive disease compared to the MAC cohort. On multivariate analysis, overall survival (OS) was not significantly different in the RIC/NMA cohort compared to the MAC cohort (hazard ratio (HR) = 1.01, 95% confidence interval (CI) = 0.79–1.29; p = 0.95). Similarly, non‐relapse mortality (NRM) (HR = 0.85, 95% CI = 0.61–1.19; p = 0.34), risk of progression/relapse (HR = 1.29; 95% CI = 0.98–1.70; p = 0.07) and therapy failure (HR = 1.14; 95% CI = 0.92–1.41, p = 0.23) were not significantly different between the two cohorts. Relative to MAC, RIC/NMA was associated with a significantly lower risk of grade 3–4 acute graft‐versus‐host disease (HR = 0.67; 95% CI = 0.46–0.99, p = 0.04). Among chemorefractory patients, there was no difference in OS, therapy failure, relapse, or NRM between RIC/NMA and MAC regimens. In conclusion, we found no association between conditioning intensity and outcomes after allo‐HCT for T‐cell NHL.
MRI imaging versus histologic volumetric estimation of residual injection laryngoplasty material
Bowen, Andrew J. , San‐Marina, Serban , Hunter, Danielle E., Voss, Stephen G. , Meloche, Ryan , Spragg, Andrew Mearns, Lohse, Christine M. , Oldenburg, Michael , Ekbom, Dale C. , Bowen, Andrew Jay , Hunter, Danielle, Voss, Stephen , Macura, Slobodan , Lohse, Christine, Ekbom, Dale , Bartemes, Kathleen R.

Mayo Clinic

Laryngoscope Investigative Otolaryngology | February 2, 2022 | Volume: 7 | Issue: 2 | Pages: 454-459

10.1002/lio2.744 | PMID 35434315 Get It

AbstractObjectivesTo examine the degree of agreement between MRI and histologically generated volumetric measurements of residual injection laryngoplasty material.MethodsFollowing left recurrent laryngeal nerve transection, rabbit vocal cords were injected with jellyfish collagen, Cymetra®, or Restylane®. Laryngeal tissue was harvested 4 or 12 weeks post injection followed by MRI imaging and histologic cross‐sectioning. Two raters estimated the volume of remaining injection material in specimens within MRI and histologic axial cross sections. Wilcoxon signed rank tests were employed to detect gross differences between inter‐rater measurements and between imaging modalities across time. Agreement between rater measurements and imaging (histology and MRI) was assessed using intra‐class correlation coefficients.ResultsData was available from 16 rabbits sacrificed at 4 weeks (n = 8) and 12 weeks (n = 8). Inter‐rater testing of MRI imaging revealed no significant differences (p > .05) between rater measurements across time points, and excellent agreement (0.93; 95% confidence interval 0.80–0.98) while histologically estimated volumes demonstrated a significant difference at 4 weeks (p < .05) and overall good agreement (0.89; 95% confidence interval 0.59–0.97). Comparison of MRI and histologically estimated volume measurements revealed significant differences at the 4‐week time point (p < .05) but not at 12 weeks (p > .05). Overall, there is only moderate agreement between MRI and histology estimates (0.72; 95% confidence interval 0.22–0.90).ConclusionsMRI imaging demonstrates good reliability and similar estimates of volume to histologically estimated measurements of residual injection laryngoplasty material at time points clinically relevant for future injection laryngoplasty experiments.Level of EvidenceNA.
Cross‐sectional amyloid and tau PET in cognitively normal older adults enrolled in the U.S. POINTER lifestyle intervention trial
Borowski, Bret, Murphy, Alice, Ward, Tyler J. , Gordineer, Leslie, Woolard, Nancy , Jagust, William J. , Lovato, Laura, Masdeu, Joseph C. , Oh, Hwamee , Aggarwal, Neelum T. , Snyder, Heather M. , Whitmer, Rachel A. , Landau, Susan , Group, the U.S. POINTER Study, Harrison, Theresa M. , Vemuri, Prashanthi , Koeppe, Robert A. , Lockhart, Samuel N. , Jung, Youngkyoo , Espeland, Mark Andrew , Harvey, Danielle , Toga, Arthur W. , Masdeu, Joseph C , Gitelman, Darren R. , Carrillo, María C. , Baker, Laura D. , DeCarli, Charles , Group, the U.S. POINTER Study

Mayo Clinic

Alzheimer's & Dementia | February 1, 2022 | Volume: 17 | Issue: S4 | Pages: No page available

10.1002/alz.055306 Get It

AbstractBackgroundThe U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) is a 2‐year randomized controlled trial to evaluate the effect of lifestyle interventions in older adults (60‐79 years) who are cognitively unimpaired but at increased risk for cognitive decline/dementia due to factors such as cardiovascular disease and family history. The POINTER Imaging ancillary study is collecting PET and MRI data to evaluate neuroimaging biomarkers of AD and cerebrovascular pathophysiology in this at‐risk sample.MethodPOINTER Imaging is actively enrolling 1250 participants, 23% from under‐represented racial/ethnic groups (URG), recruited from five U.S. POINTER clinical sites. Participants have undergone PET imaging with [18F]Florbetaben (FBB) to measure Aβ and [18F]MK‐6240 to measure tau burden, as well as MRI to measure brain morphometry, white matter hyperintensities and cerebral blood flow. FBB and MK‐6240 data were quality checked, pre‐processed, and quantified using previously validated methods. PET images were coregistered to a structural MRI, which was also used to create FreeSurfer‐defined reference regions and regions of interest. We examined PET imaging measures (global Aβ, regional tau) and basic demographic (age, sex, race/ethnicity) characteristics of the sample.Result96 participants (mean age 69.3±5.0) have been enrolled in POINTER Imaging. Of these, 59 (61%) are women and 22 (23%) are URG, which is similar to rates of women (75%) and URG (22%) in the main trial. This dataset is <10% of targeted enrollment, was predominantly recruited from 2/5 clinical sites and may not represent the final imaging cohort. FBB quantification (N=20) revealed a mean cortical summary SUVR of 1.09±0.12 (19.6±18.4 centiloids) (whole cerebellum normalization; previously validated positivity threshold=1.08), and 8/20 (40%) of these participants were Aβ+ (Fig. 1A). MK‐6240 quantification (N=23) showed predominantly no/minimal binding with a few exceptions in medial and lateral temporal lobes (Fig. 1B&C).ConclusionThe POINTER imaging study is meeting the target URG enrollment and representative of the main U.S. POINTER trial. Higher frequency of Aβ positivity than published in population cohorts coupled with greater cardiovascular risk factors among POINTER participants highlights our success in recruiting individuals at increased risk of cognitive decline.
Early Post-Hospitalization Hemoglobin Recovery and Clinical Outcomes in Survivors of Critical Illness: A Population-Based Cohort Study
Warner, Matthew A. , Hanson, Andrew C. , Schulte, Phillip J. , Roubinian, Nareg H. , Storlie, Curt B., Demuth, Gabriel , Kor, Daryl J. , Storlie, Curt, Warner, Matthew A , Gajic, Ognjen

Mayo Clinic

Journal of Intensive Care Medicine | February 1, 2022 | Volume: 37 | Issue: 8 | Pages: 1067-1074

10.1177/08850666211069098 | PMID 35103495 Get It

Anemia is common during critical illness, is associated with adverse clinical outcomes, and often persists after hospitalization. The goal of this investigation is to assess the relationships between post-hospitalization hemoglobin recovery and clinical outcomes after survival of critical illness. This is a population-based observational study of adults (≥18 years) surviving hospitalization for critical illness between January 1, 2010 and December 31, 2016 in Olmsted County, Minnesota, United States with hemoglobin concentrations and clinical outcomes assessed through one-year post-hospitalization. Multi-state proportional hazards models were utilized to assess the relationships between 1-month post-hospitalization hemoglobin recovery and hospital readmission or death through one-year after discharge. Among 6460 patients that survived hospitalization for critical illness during the study period, 2736 (42%) were alive, not hospitalized, and had available hemoglobin concentrations assessed at 1-month post-index hospitalization. Median (interquartile range) age was 69 (56, 80) years with 54% of male gender. Overall, 86% of patients had anemia at the time of hospital discharge, with median discharge hemoglobin concentrations of 10.2 (9.1, 11.6) g/dL. In adjusted analyses, each 1 g/dL increase in 1-month hemoglobin recovery was associated with decreased instantaneous hazard for hospital readmission (HR 0.87 [95% CI 0.84-0.90]; p < 0.001) and lower mortality (HR 0.82 [95% CI 0.75-0.89]; p < 0.001) through one-year post-hospitalization. The results were consistent in multiple pre-defined sensitivity analyses. Impaired early post-hospitalization hemoglobin recovery is associated with inferior clinical outcomes in the first year of survival after critical illness. Additional investigations are warranted to evaluate these relationships.